Healthcare -
Biotechnology - NASDAQ - US
$ 4.55
-1.73 %
$ 156 M
Market Cap
-1.72
P/E
TARA - COST OF REVENUE
Cost of Revenue TARA - Protara Therapeutics, Inc.
341 K
LAST VALUE
-45.94%
2 YEAR CAGR
24.28%
5 YEAR CAGR
28.87%
10 YEAR CAGR